InsiderClue
Insiders · Profile

Lucera Erick

Chief Financial Officer at Dyne Therapeutics · EVP, CHIEF FINANCIAL OFFICER at Editas Medicine · Director at Beyond Air. Filing since 16 Mar 2023. CIK 0001697616

DYN Dyne Therapeutics, Inc. Chief Financial Officer · 4 trades EDIT Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER · 2 trades XAIR Beyond Air, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DYN Dyne Therapeutics, Inc.
13 Aug 2026
Chief Financial Officer
Sold on a plan
1,797
$47.23K
1.5%
DYN Dyne Therapeutics, Inc.
25 Jun 2026
Chief Financial Officer
Sold at will
2,362
$48.11K
1.9%
DYN Dyne Therapeutics, Inc.
13 May 2026
Chief Financial Officer
Sold on a plan
1,448
$26.59K
1.2%
DYN Dyne Therapeutics, Inc.
1 Apr 2026
Chief Financial Officer
Sold on a plan
5,727
$106.75K
4.4%
EDIT Editas Medicine, Inc.
4 Mar 2025
EVP, CHIEF FINANCIAL OFFICER
Sold on a plan
4,109
$7.03K
3.5%
XAIR Beyond Air, Inc.
14 Aug 2024
Director
Bought
39,266
$15.57K
904%
EDIT Editas Medicine, Inc.
20 May 2024
EVP, CHIEF FINANCIAL OFFICER
Sold on a plan
22,337
$125.40K
16.1%
XAIR Beyond Air, Inc.
16 Mar 2023
Director
Bought
2,000
$13.63K
85.4%
8 decisions on file.